Eikonizo Therapeutics is a biopharmaceutical company.
Eikonizo Therapeutics's investors include Novo Nordisk, National Institute of Neurological Disorders and Stroke.
Eikonizo Therapeutics is headquartered in Cambridge, United States.
Eikonizo Therapeutics is a biopharmaceutical company.
Eikonizo Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eikonizo Therapeutics — Funding & Investors." VCBacked, October 9, 2025, https://www.vcbacked.co/company/eikonizo-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Eikonizo Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/eikonizo-therapeutics
{{cite web |title=Eikonizo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/eikonizo-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated